Novel Ultrasound and DCE-MRI Analyses After Antiangiogenic Treatment With a Selective VEGF Receptor Inhibitor

Ultrasound in Medicine and Biology - Netherlands
doi 10.1016/j.ultrasmedbio.2011.03.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Heterogeneity of Tumor Vasculature and Antiangiogenic Intervention: Insights From MR Angiography and DCE-MRI

PLoS ONE
Multidisciplinary
2014English

Characterization of a Novel PERK Kinase Inhibitor With Antitumor and Antiangiogenic Activity

Cancer Research
Cancer ResearchOncology
2013English

DCE-MRI: A Review and Applications in Veterinary Oncology

Veterinary and Comparative Oncology
Veterinary
2011English

A Novel, Highly Potent and Selective Phosphodiesterase-9 Inhibitor for the Treatment of Sickle Cell Disease

Haematologica
Hematology
2019English

Principal Component Analysis of Breast DCE-MRI Adjusted With a Model-Based Method

Journal of Magnetic Resonance Imaging
Nuclear MedicineRadiologyImaging
2009English

Cytotoxic and Antiangiogenic Activity of AW464 (NSC 706704), a Novel Thioredoxin Inhibitor: An in Vitro Study

British Journal of Cancer
Cancer ResearchOncology
2005English

AE9C90CB: A Novel, Bladder-Selective Muscarinic Receptor Antagonist for the Treatment of Overactive Bladder

British Journal of Pharmacology
Pharmacology
2010English

DCE-MRI of Locally-Advanced Carcinoma of the Uterine Cervix: Tofts Analysis Versus Non-Model-Based Analyses

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2020English

Complement C2 Receptor Inhibitor Trispanning: A Novel Human Complement Inhibitory Receptor

Journal of Immunology
AllergyImmunology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy